The failure to meet quality requirements consists in exceeding the lower specification limit for pyridoxine hydrochloride (vitamin B6) release in stability testing under the registered storage conditions. Potential effects: possible reduced treatment effectiveness and lack of the expected supplementation effect.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use Magne B6 tablets from batches GV380, GV381, GV382 and HV006. Patients should check the batch number of their pack and, if it matches, return the product to a pharmacy or consult a pharmacis...
The Chief Pharmaceutical Inspector withdrew batches GV380, GV381, GV382 and HV006 of Magne B6 from the market throughout Poland and prohibited their further placing on the market, granting the decisio...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related